Salt or sugar for your injured brain? A meta-analysis of randomised controlled trials of mannitol versus hypertonic sodium solutions to manage raised intracranial pressure in traumatic brain injury
@article{Rickard2013SaltOS, title={Salt or sugar for your injured brain? A meta-analysis of randomised controlled trials of mannitol versus hypertonic sodium solutions to manage raised intracranial pressure in traumatic brain injury}, author={Annette C Rickard and J E Smith and Portia Newell and A Bailey and Anthony Kehoe and Clifford Mann}, journal={Emergency Medicine Journal}, year={2013}, volume={31}, pages={679 - 683} }
Background Rising intracranial pressure (ICP) is a poor prognostic indicator in traumatic brain injury (TBI). Both mannitol and hypertonic sodium solutions are used to treat raised ICP in patients with TBI. Objective This meta-analysis compares the use of mannitol versus hypertonic sodium solutions for ICP control in patients with TBI. Data sources and study eligibility Randomised clinical trials in adults with TBI and evidence of raised ICP, which compare the effect on ICP of hypertonic sodium…
66 Citations
Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials
- MedicineNeurosurgical Review
- 2018
The results do not lend a specific recommendation to select hypertonic saline or mannitol as a first-line for the patients with elevated ICP caused by TBI, however, for the refractory intracranial hypertension, hypertoni saline seems to be preferred.
Hypertonic saline versus mannitol for the treatment of increased intracranial pressure in traumatic brain injury.
- MedicineJournal of the American Association of Nurse Practitioners
- 2019
Hypertonic saline is an effective alternative to mannitol for increased ICP, and Providers should consider the properties of each agent, adverse effects, and potential benefits when selecting a hyperosmotic agent.
A Systematic Review of Randomized Controlled Trials Comparing Hypertonic Sodium Solutions and Mannitol for Traumatic Brain Injury
- MedicineThe Annals of pharmacotherapy
- 2016
Clinical important differences in mortality, neurological outcomes, and ICP reduction were not observed between HTS or mannitol in the management of severe TBI, and HTS appears to lead to fewer ICP treatment failures.
Hypertonic Saline Versus Mannitol for Traumatic Brain Injury: A Systematic Review and Meta-analysis With Trial Sequential Analysis
- MedicineJournal of neurosurgical anesthesiology
- 2019
There are indications that HS might be superior to mannitol in the treatment of TBI-related raised ICP, however, there are insufficient data to reach a definitive conclusion, and further studies are warranted.
Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
- MedicineThe Cochrane database of systematic reviews
- 2019
The comparative efficacy and safety of hypertonic saline versus other ICP-lowering agents in the management of acute TBI was assessed, with concerns about missing data for important outcomes.
Hypertonic saline and mannitol in patients with traumatic brain injury
- MedicineMedicine
- 2020
3% hypertonic saline has a more sustained effect on intracranial pressure and can effectively increase cerebral perfusion pressure.
Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury.
- MedicineThe Cochrane database of systematic reviews
- 2020
To assess the comparative efficacy and safety of hypertonic saline versus other intracranial pressure-lowering agents in the management of acute traumatic brain injury, six randomised controlled trials were searched.
Osmotic Therapy in Traumatic Brain Injury
- MedicineCurrent Trauma Reports
- 2018
A sufficiently powered, multicenter, randomized controlled trial focusing on hypertonic saline and mannitol in severe TBI patients is necessary to determine whether a particular hyperosmolar agent independently contributes to a superior neurological outcome.
Hypertonic saline in severe traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials.
- MedicineCJEM
- 2016
Based on the current level of evidence pertaining to mortality or control of intracranial pressure, hypertonic saline could not be recommended as a first-line agent for managing patients with severe traumatic brain injury.
Intravenous fluids in traumatic brain injury: what's the solution?
- MedicineCurrent opinion in critical care
- 2014
In patients with TBI, intravenous fluids are integral to management; they may be both a source of harm and a potential therapy to limit secondary brain injury and refined usage may improve patient outcomes.
References
SHOWING 1-10 OF 31 REFERENCES
Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients
- MedicineIntensive Care Medicine
- 2008
Acute infusion of a sodium lactate-based hyperosmolar solution is effective in treating intracranial hypertension following traumatic brain injury and long-term outcome was better in terms of GOS in those receiving as compared to mannitol.
The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
- MedicineThe Journal of trauma
- 2009
Based on this retrospective analysis, 23.4% HTS is more efficacious than mannitol in reducing ICP and may become the agent of choice for the management of elevated ICP after TBI.
Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials*
- MedicineCritical care medicine
- 2011
The findings suggest that hypertonic saline may be superior to the current standard of care and argue for a large, multicenter, randomized trial to definitively establish the first-line medical therapy for intracranial hypertension.
Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension
- MedicineJournal of Neurology, Neurosurgery, and Psychiatry
- 2009
In patients with severe TBI and elevated ICP refractory to previous mannitol treatment, 7.5% hypertonic saline administered as second tier therapy is associated with a significant increase in brain oxygenation, and improved cerebral and systemic haemodynamics.
Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries.
- MedicineJournal of neurosurgery
- 2011
No difference between the 2 medications could be found with respect to the extent of reduction of ICP or duration of action in patients treated for severe head injury at their hospital during 2006-2008.
Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial.
- Medicine, PsychologyJournal of neurosurgery
- 2000
Treatment protocols for the management of severe head injury should emphasize the immediate reduction of raised ICP to less than 20 mm Hg if possible, as a CPP greater than 60mm Hg appears to have little influence on the outcome of patients with severe head injuries.
Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury*
- MedicineCritical care medicine
- 2005
When given in an equimolar, rapid, intravenous infusion, HSD reduces intracranial pressure more effectively than mannitol.
Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis.
- MedicineJournal of neurosurgery
- 2012
A greater part of the data suggest that HTS given as either a bolus or continuous infusion can be more effective than mannitol in reducing episodes of elevated ICP.
Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol.
- MedicineCritical care medicine
- 2003
Giving 2 mL/kg hypertonic saline solution (approximately 480 mOsm/70 kg body weight) is an effective and safe initial treatment for intracranial hypertension episodes in head-trauma patients when osmotherapy is indicated.
Correction of intracranial hypertension syndrome using hyperosmolar solutions in patients with severe brain damage (multicenter randomized clinical study)
- Medicine
- 2009
Intravenous infusion of the solutions was found to induce a reduction in ICP; however, this was most pronounced (by 30-40%) and longer (up to 4 hours) when HyperHAES solution was used.